Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A Develops oligonucleotide therapeutics targeting chronic hepatitis B | $120M | Series CSeries C+ | Biotech | United States | Investors |
Ranked by rounds participated in · From Jan 1, 2026
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| C CivilGridCompany profile Provides collaborative maps and design workflows for infrastructure projects Provides collaborative maps and design workflows for infrastructure projects | $26M | Series A | Proptech | United States | Investors |
| H All-in-one payments platform built for small and mid-sized businesses | CA$53M | Series CSeries C+ | Fintech | Canada | Investors |
| Y YardstikCompany profile Combines fraud prevention, background screening and continuous workforce monitoring Combines fraud prevention, background screening and continuous workforce monitoring | $30M | Series B | Enterprise software | United States | Investors |
| S SocureCompany profile Provides AI-native identity verification and fraud/compliance risk infrastructure Provides AI-native identity verification and fraud/compliance risk infrastructure | $156M | Growth | Fintech | United States | Investors |
| QE Quaise EnergyCompany profile Develops millimeter-wave drilling technology to access superhot geothermal energy resources Develops millimeter-wave drilling technology to access superhot geothermal energy resources | $35M | StrategicUndisclosed | Climate tech | United States | Investors |
| PT ProFound TherapeuticsCompany profile Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia | $35M | StrategicUndisclosed | Biotech | United States | Investors |
| f fileAICompany profile Automates unstructured enterprise data capture and validation into governed, audit-ready workflows Automates unstructured enterprise data capture and validation into governed, audit-ready workflows | Undisclosed | StrategicUndisclosed | Enterprise software | Singapore | Investors |
| A ArintraCompany profile AI platform automating medical coding and revenue assurance for health systems AI platform automating medical coding and revenue assurance for health systems | $25M | Series B | Healthtech | United States | Investors |
| P Sells purified water in reusable aluminum bottles as a plastic-free alternative | Undisclosed | StrategicUndisclosed | Foodtech | United States | Investors |